Form 4: Select Medical Holdings Corp: Ely Reports Merger-Related Stock Conversion

James S. Ely III, a Director at Select Medical Holdings Corp, reported the conversion of his common stock into cash consideration as part of a merger agreement.

Summary

• James S. Ely III, a Director of Select Medical Holdings Corporation, has filed a Form 4 reporting a transaction related to the company's merger.
• The transaction, dated June 30, 2026, involved the conversion of common stock into cash.
• Each share of common stock was converted into the right to receive $16.50 per share in cash, without interest, as per the Merger Agreement.
• This also includes unvested shares of Company common stock subject to forfeiture conditions, which vested in full prior to the merger and were converted into the same cash consideration, less applicable taxes.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports on a completed transaction (merger) and the conversion of ownership rather than new financial performance or strategic initiatives.

Positives

• The merger agreement provides a cash payout of $16.50 per share to shareholders, including Director James S. Ely III.
• All outstanding shares, including unvested restricted shares, were converted into this cash consideration, indicating a full realization of value for these holdings at the time of the merger.

Negatives

• The filing indicates a conversion of stock to cash, suggesting the end of public trading for Select Medical Holdings Corporation as an independent entity.
• The cash consideration is subject to applicable tax withholdings.

Risks

• The primary risk is the completion of the merger itself, as outlined in the Agreement and Plan of Merger.
• Potential risks associated with the conversion of securities and the receipt of merger consideration, such as tax implications, are present.

Future Outlook

The filing primarily reports on a completed transaction (merger) rather than providing forward-looking financial guidance. The future outlook is tied to the successful completion and integration of the merger.

Management Comments

• The Merger Agreement converted each of the Reporting Person's shares of common stock into the right to receive $16.50 per share in cash without interest.
• Each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in full as of immediately prior to the effective time of the merger and was automatically converted into the right to receive the Merger Consideration, less any applicable tax withholdings.

Industry Context

StockSavvy.ai notes that this Form 4 filing signifies a significant corporate event for Select Medical Holdings Corporation, likely indicating the final stages of a merger or acquisition that will result in the delisting of the company's stock.

Stakeholder Impact

• Shareholders: Will receive $16.50 per share in cash for their common stock, subject to tax withholdings.
• Management/Directors: As a director, James S. Ely III is subject to reporting requirements for his stock transactions related to the merger.

Next Steps

• Completion of the merger as per the Agreement and Plan of Merger.
• Receipt of merger consideration by shareholders, including Director Ely.

Key Dates

Keywords

Select Medical Holdings Corp, SEM, Form 4, Merger, Stock Conversion, Beneficial Ownership, Director, SEC Filing, James S. Ely III